BSEAGM/EGMMgmt Change24 Sept 2026
Mangalam Drugs & Organics Ltd
Intimation under Regulation 44 of SEBI ( LODR), 2015 regarding voting results and combined scrutinizer report for 53rd Annual General Meeting of the Company.
Mangalam Drugs & Organics Ltd has announced the voting results and combined scrutinizer report for its 53rd Annual General Meeting (AGM). The company has passed all the resolutions with the requisite majority. The resolutions include the consideration and adoption of the audited standalone and consolidated financial statements, appointment of an executive director, appointment of statutory auditors, ratification of remuneration payable to cost auditors, approval of materiality of related party transactions, and appointment of secretarial auditors.
BSEAGM/EGM23 Sept 2026
Mangalam Drugs & Organics Ltd
Intimation for the Proceedings of the 53rd Annual General Meeting of the Company held on Wednesday, 23/09/2026 , started at 3:00 pm and concluded at 4:00 pm through video conferencing under Regulation 30 of SEBI (LODR), 2015.
Mangalam Drugs & Organics Ltd held its 53rd Annual General Meeting (AGM) on September 23, 2026, through video conferencing, where the business was transacted as per the AGM notice. The meeting was attended by the directors and other officials, and the resolutions were passed through remote e-voting facility.
BSEGeneral▼ NegativeDebt Restruc.15 Sept 2026
Mangalam Drugs & Organics Ltd
Subsequent Disclosure under Regulation 30 Para A of Schedule III of LODR 2015 for the bank default of the Company
Mangalam Drugs & Organics Ltd has defaulted on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days. The company has made subsequent intimation declaring the default and is making arrangements to pay the overdue amount as soon as possible.
BSECompany UpdateMgmt Change15 Sept 2026
Mangalam Drugs and Organics Limited
Mangalam Drugs and Organics Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Mangalam Drugs and Organics Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change15 Sept 2026
Mangalam Drugs and Organics Limited
Mangalam Drugs and Organics Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Mangalam Drugs and Organics Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change15 Sept 2026
Mangalam Drugs & Organics Ltd
Disclosure under Regulation 30 of LODR, 2015 for the appointment of Mr. Prabhakar Raghunath Zavar (DIN: 11940187) as the Additional Independent Director ( Non- Executive) for term of 5 years wef. 15/09/2026 at the Board Meeting held on today, Tuesday, September 15th, 2026, subject to consent of Shareholders at the ensuing EGM.
Mangalam Drugs & Organics Ltd has appointed Mr. Prabhakar Raghunath Zavar as an Additional Director (Independent Non-Executive Director) for a term of five years, subject to shareholder approval.
BSEBoard MeetingMgmt Change15 Sept 2026
Mangalam Drugs & Organics Ltd
Outcome of Board Meeting pursuant to Regulation 30 of LODR for appointment of Mr. Prabhakar Raghunath Zavar as the Additional Indepedent Director ( Non- Executive) for term of 5 years wef. September 15th, 2026, subject to consent of shareholders at ensuing EGM.
Mangalam Drugs & Organics Ltd has appointed Mr. Prabhakar Raghunath Zavar as an Additional Director (Independent Non-Executive Director) for a term of 5 years, subject to shareholder approval at the ensuing EGM.
BSECompany Update1 Sept 2026
Mangalam Drugs & Organics Ltd
Newspaper publication regarding Notice of 53rd Annual General Meeting to be held on 23rd September, 2026 and information on E-voting.
Mangalam Drugs & Organics Ltd has published a notice of its 53rd Annual General Meeting (AGM) to be held on September 23, 2026, through video conferencing. The company has also announced the details of remote e-voting, which will commence on September 19, 2026, and end on September 22, 2026.
BSEOthersResults31 Aug 2026
Mangalam Drugs & Organics Ltd
Intimation of dispatch of Annual Report for 53rd Annual General Meeting for the financial year 2025-26 to be held on Wednesday, September 23rd, 2026 to the Shareholders of the Company.
Mangalam Drugs & Organics Ltd has announced the dispatch of its Annual Report for the 53rd Annual General Meeting for the financial year 2025-26. The meeting will be held on September 23, 2026, through video conference. The report includes the notice convening the AGM and is being sent to shareholders through electronic mode.
BSEAGM/EGM31 Aug 2026
Mangalam Drugs & Organics Ltd
Annual Report of the Company, Notice convening 53rd Annual General Meeting for the financial year 2025-26 to be Held on Wednesday, September 23rd, 2026 and Intimation of Cut-off Date for ....
Mangalam Drugs & Organics Ltd has announced its 53rd Annual General Meeting (AGM) for the financial year 2025-26, to be held on September 23rd, 2026, through video conference. The company has also released its annual report for the same period, which includes the notice convening the AGM and other corporate governance information.
BSEOthers▼ NegativeDebt Restruc.17 Aug 2026
Mangalam Drugs & Organics Ltd
Intimation of default under Para A sub- paragraph 6 Schedule III-subsequent default
Mangalam Drugs & Organics Ltd has defaulted on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days, as per the regulations of the exchange.
BSECompany UpdateResults13 Aug 2026
Mangalam Drugs & Organics Ltd
Newspaper publication for declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2026
Mangalam Drugs & Organics Ltd has published un-audited financial results for the quarter ended June 30, 2026, and has also provided details of a borrower's outstanding loan and credit facilities.
BSECompany UpdateMgmt Change12 Aug 2026
Mangalam Drugs & Organics Ltd
Appointment of Secretarial Auditor of the Company for term of 5 years from F.Y. 2026-27 to 2030-31 subject to approval of shareholders in ensuing 53rd AGM of the Company
Mangalam Drugs & Organics Ltd has announced the appointment of Secretarial Auditor and Statutory Auditor for a term of 5 years, subject to shareholder approval. The company has also declared unaudited financial results for the quarter ended June 30, 2026, with no modified opinions from the statutory auditors.
BSECompany UpdateAuditor Change12 Aug 2026
Mangalam Drugs & Organics Ltd
Appointment of Statutory Auditor for the period of 5 years subject to approval of sharehoders at ensuing 53rd Annual General meeting.
Mangalam Drugs & Organics Ltd has announced the appointment of M/s SN. Nanda & Co, Chartered Accountants as the Statutory Auditors of the Company for a term of five consecutive years, commencing from the conclusion of the 53rd AGM till the conclusion of the 58th AGM, subject to the approval of the shareholders at the ensuing AGM.
BSEResultResults12 Aug 2026
Mangalam Drugs & Organics Ltd
Declaration of Un-audited Financial results (Standalone & Consolidated) for the quarter ended 30th June, 2026
Mangalam Drugs & Organics Ltd has declared its un-audited financial results for the quarter ended June 30, 2026, with the statutory auditors not expressing any modified opinions in their limited review reports.
BSEBoard MeetingResults12 Aug 2026
Mangalam Drugs & Organics Ltd
Outcome of Board meeting held on 12th August, 2026 interalia for approval of Un-Audited Financial results (Standalone & Consolidated) for the quarter ended 30th June, 2026
Mangalam Drugs & Organics Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, along with the appointment of secretarial auditors and statutory auditors for a period of five consecutive years.
BSECompany UpdateAuditor Change6 Aug 2026
Mangalam Drugs & Organics Ltd
Intimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR), Regulations, 2015 regarding resiagntion tendered by Ragini Chokshi & Co., Secretarial Auditor of the Company ....
Mangalam Drugs & Organics Ltd has announced the resignation of its Secretarial Auditor, Ragini Chokshi & Co., effective August 4, 2026, due to pre-occupancy with professional commitments.
BSEBoard MeetingResults5 Aug 2026
Mangalam Drugs & Organics Ltd
Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Prior Intimation ....
Mangalam Drugs & Organics Ltd has scheduled a Board Meeting on August 12th, 2026 to consider and approve un-audited financial results for the quarter ended June 30, 2026, along with the appointment of secretarial auditors and statutory auditors.